Assay Shown to Help Detect Prostate Cancer Patients at Risk of Metastasis

Assay Shown to Help Detect Prostate Cancer Patients at Risk of Metastasis
An assay may help to determine those prostate cancer patients at risk of metastasis, a study reports. It works by  identifying a molecular subgroup of primary prostate cancer to detect patients who might have metastatic recurrence following radical prostatectomy. The study that validated the assay, “Molecular Subgroup of Primary Prostate Cancer Presenting with Metastatic Biology,” was published in the Journal of European Urology. “An unbiased discovery approach was used to identify a molecular subtype of primary prostate cancer that demonstrated metastatic biology,” Richard Kennedy, vice president and medical director of 
Subscribe or to access all post and page content.